1. Assessment of the MAGIC recommendations in context of evolving evidence based on the use of PICC in ICU.
- Author
-
Pinelli F, Little A, Kokotis K, Alsbrooks K, and Pittiruti M
- Subjects
- Humans, Intensive Care Units, Critical Care, Catheterization, Central Venous, Central Venous Catheters, Catheterization, Peripheral
- Abstract
The goal of the 2015 Michigan Appropriateness Guide for Intravenous Catheters (MAGIC) was to define indications and appropriate practices for peripherally inserted central catheters (PICC) use; however, MAGIC recommendations virtually reduced the use of PICC in hospital settings, including critical care. The aim of this review is to present an assessment of the MAGIC guidelines, considering contemporary evidence to date. The validity of the MAGIC recommendations and their applicability to current practice are called into question given important concerns with the methodology for their development (e.g. high volume of clinical scenarios for evaluation) and the supporting evidence used. There is a considerable amount of contemporary evidence not considered in MAGIC that reports on evolving practices, techniques, and technologies targeted to reduce complications associated with central venous access devices (CVADs). Recent evidence dictates that CVADs are necessary in the intensive care unit (ICU), and that PICCs are a safe, reliable, and appropriate type of central lines, which cannot be replaced in several ICU situations. In light of evolving evidence and practice, as well as the methodological concerns identified, the MAGIC guidelines should be revisited. It is also recommended to create a clinical assessment tool that identifies potential uses of specific CVADs, based on patient needs. The choice of the CVAD should be based on unique clinical considerations and current scientific evidence, not on fears informed by antiquated data., Competing Interests: Declaration of conflicting interestsThe author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: F.P. received reimbursements and/or fees for lectures or consultancy from Bard, BBraun, Becton & Dickinson, Medcomp, MSD, Orion Pharma, Teleflex, and Vygon. K.A. and K.K. are employees of Becton & Dickinson and Company (Franklin Lakes, NJ, USA).
- Published
- 2023
- Full Text
- View/download PDF